IRadimed Corporation (IRMD)
53.21
-0.70 (-1.30%)
At close: Mar 03, 2025, 3:59 PM
53.29
0.15%
After-hours: Mar 03, 2025, 04:00 PM EST
IRadimed Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Revenue | 73.24M | 65.56M | 53.3M | 41.81M | 31.72M | 38.52M | 30.44M | 23.08M | 32.5M | 31.59M | 15.65M | 11.34M | 7.69M |
| Cost of Revenue | 16.89M | 15.4M | 12.02M | 9.76M | 8.14M | 8.82M | 7.21M | 5.57M | 6.15M | 5.84M | 3.4M | 2.85M | 2.13M |
| Gross Profit | 56.35M | 50.16M | 41.28M | 32.05M | 23.57M | 29.7M | 23.23M | 17.51M | 26.34M | 25.75M | 12.25M | 8.49M | 5.56M |
| Operating Income | 21.96M | 20.04M | 15.63M | 9.82M | -756.09K | 8.65M | 6M | 1.29M | 10.92M | 11.51M | 3.07M | 2.79M | 1.42M |
| Interest Income | n/a | 1.86M | 581.85K | 34.81K | 132.19K | 388.8K | 238.11K | 122.58K | 126.42K | 148.91K | 5.7K | n/a | n/a |
| Pretax Income | 24.28M | 21.74M | 16.18M | 9.84M | -616.88K | 9.04M | 6.2M | 1.4M | 10.95M | 11.63M | 3.02M | 2.78M | 1.43M |
| Net Income | 19.23M | 17.19M | 12.83M | 9.33M | 1.37M | 9.63M | 6.3M | 499.76K | 7.21M | 7.53M | 2.05M | 1.94M | 966.09K |
| Selling & General & Admin | 31.55M | 27.26M | 23.38M | 20.33M | 22.43M | 19.62M | 15.71M | 14.5M | 14.07M | 12.48M | 8.11M | 4.69M | 3.48M |
| Research & Development | 2.83M | 2.86M | 2.28M | 1.91M | 1.9M | 1.43M | 1.52M | 1.72M | 1.35M | 1.76M | 1.07M | 1.01M | 654.07K |
| Other Expenses | n/a | n/a | 553.1K | 18.61K | 139.21K | 395.91K | 193.54K | 111.38K | 32.68K | 121.39K | -48.55K | -3.46K | 7.42K |
| Operating Expenses | 34.39M | 30.12M | 25.65M | 22.23M | 24.33M | 21.05M | 17.22M | 16.23M | 15.42M | 14.24M | 9.18M | 5.7M | 4.13M |
| Interest Expense | n/a | n/a | 581.85K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | 15.62M | 12.14M | 12.68M | 10.56M | 10.16M | 9.17M | 7M | 5.5M | 5.28M | 4.71M | 3.3M | 2.3M | 1.93M |
| Cost & Expenses | 51.28M | 45.53M | 37.68M | 32M | 32.47M | 29.87M | 24.44M | 21.8M | 21.58M | 20.08M | 12.59M | 8.55M | 6.26M |
| Income Tax | 5.04M | 4.55M | 3.35M | 510.82K | -1.99M | -587.64K | -106.14K | 896.62K | 3.74M | 4.1M | 966.98K | 846.88K | 465.98K |
| Shares Outstanding (Basic) | 12.67M | 12.6M | 12.56M | 12.35M | 12.12M | 11.28M | 12.11M | 10.64M | 10.82M | 11M | 8.74M | 10.42M | 10.42M |
| Shares Outstanding (Diluted) | 12.78M | 12.72M | 12.64M | 12.59M | 12.44M | 12.28M | 12.11M | 11.72M | 11.99M | 12.56M | 10.22M | 10.42M | 10.42M |
| EPS (Basic) | 1.52 | 1.36 | 1.02 | 0.76 | 0.11 | 0.85 | 0.52 | 0.05 | 0.67 | 0.68 | 0.23 | 0.19 | 0.09 |
| EPS (Diluted) | 1.50 | 1.35 | 1.02 | 0.74 | 0.11 | 0.78 | 0.52 | 0.04 | 0.60 | 0.60 | 0.20 | 0.19 | 0.09 |
| EBITDA | 21.96M | 20.8M | 16.3M | 11.22M | 582.73K | 9.89M | 7.11M | 2.59M | 11.17M | 11.51M | 3.21M | 2.93M | 1.53M |
| Depreciation & Amortization | n/a | 765.18K | 670.67K | 634.01K | 603.6K | 591.18K | 559.73K | 445.27K | 248.3K | 223.94K | 149.06K | 139.04K | 106.28K |